FM mitigates NF-κB/STAT3 activation triggered by CD8+NKG2D+ cells -and enhances oncolytic efficacy of CD8+NKG2D+ cells on HCC cells. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.